Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BMS And WuXi Team Up For Testing

by Jean-François Tremblay
March 14, 2011 | A version of this story appeared in Volume 89, Issue 11

China’s largest contract research organization, WuXi PharmaTech, will set up a lab in Shanghai to conduct drug stability studies exclusively for Bristol-Myers Squibb. The data generated will support BMS’s global marketing applications for small-molecule new chemical entities. The new center will occupy 25,000 sq ft of space. A WuXi-employed staff will manage samples, conduct stability studies, and test for quality in support of all of BMS’s new product dossiers. In 2009, the Indian contract research organization Syngene opened a 200,000-sq-ft research facility in Bangalore, India, that is dedicated to BMS.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.